a month ago
NBIX
AnalystsJoshua SchimmerJoshua Schimmer's Stock Forecasts
AnalystsJoshua Schimmer
Analyst Ranking
Top 2%
#101 out of 5510 analysts
Average Return
+34.46%
Win Rate
53%101 out of 189
Risk vs Reward
Poor
Good
Joshua Schimmer's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Longboard Pharmaceuticals IncLBPH | +1,051.84% | $5.17 | $59.55 | 2023-10-24 - 2024-10-23 | Strong Buy |
Longboard Pharmaceuticals IncLBPH | +986.59% | $5.52 | $59.98 | 2023-12-20 - 2024-11-29 | Strong Buy |
Longboard Pharmaceuticals IncLBPH | +963.48% | $5.64 | $59.98 | 2023-12-19 - 2024-11-29 | Strong Buy |
Longboard Pharmaceuticals IncLBPH | +227.58% | $18.31 | $59.98 | 2024-04-10 - 2024-11-29 | Strong Buy |
Trevi Therapeutics IncTRVI | +227.19% | $5.70 | $18.65 | 2025-07-01 - 2026-06-30 | Strong Buy |
Joshua Schimmer Analyst Color
Get additional color on Joshua Schimmer's coverage of popular stocks
3 months ago
SPRY
7 months ago
NUVL
10 months ago
PVLA
10 months ago
MIRM
10 months ago
CABA
a year ago
RCKT
2 years ago
MIRM
2 years ago
BBIO
3 years ago
LBPH
3 years ago
LBPH
3 years ago
VTYX
3 years ago
LBPH
Joshua Schimmer's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Invivyd IncIVVD | 2 | Strong Buy | $10.00 | +1,188.66% | Reiterates | 16 days ago |
Apnimed IncAPMD | 1 | Strong Buy | $60.00 | +123.88% | Initiates Coverage On | 18 days ago |
Insmed IncINSM | 6 | Buy | $170.00 | +33.56% | Maintains | a month ago |
Trevi Therapeutics IncTRVI | 2 | Strong Buy | $30.00 | +88.56% | Maintains | a month ago |
Neurocrine Biosciences IncNBIX | 3 | Strong Buy | $215.00 | +37.32% | Maintains | a month ago |
Crinetics Pharmaceuticals IncCRNX | 7 | Hold | N/A | N/A | Downgrades | 2 months ago |
Nuvalent IncNUVL | 3 | Hold | N/A | N/A | Downgrades | 3 months ago |
Ars Pharmaceuticals IncSPRY | 5 | Strong Buy | $30.00 | +492.89% | Maintains | 3 months ago |
Ascendis Pharma AASND | 5 | Buy | $329.00 | +25.94% | Maintains | 4 months ago |
Artiva Biotherapeutics IncARTV | 3 | Strong Buy | $40.00 | +283.88% | Maintains | 4 months ago |
Cabaletta Bio IncCABA | 8 | Strong Buy | $30.00 | +994.89% | Reiterates | 4 months ago |
Rocket Pharmaceuticals IncRCKT | 9 | Strong Buy | $10.00 | +187.36% | Maintains | 7 months ago |
Janux Therapeutics IncJANX | 8 | Strong Buy | $100.00 | +465.61% | Maintains | 7 months ago |
Mirum Pharmaceuticals IncMIRM | 9 | Strong Buy | $130.00 | +29.21% | Maintains | 9 months ago |
Diamedica Therapeutics IncDMAC | 1 | Strong Buy | $25.00 | +286.40% | Initiates Coverage On | 10 months ago |
Palvella Therapeutics IncPVLA | 1 | Strong Buy | $200.00 | +32.99% | Maintains | 10 months ago |
Bridgebio Pharma IncBBIO | 13 | Strong Buy | $110.00 | +51.72% | Maintains | 10 months ago |
Avidity Biosciences IncRNAM | 7 | Buy | $65.00 | +340.68% | Maintains | a year ago |
Cg Oncology IncCGON | 5 | Strong Buy | $75.00 | N/A | Reiterates | a year ago |
Denali Therapeutics IncDNLI | 4 | Strong Buy | N/A | N/A | Reiterates | a year ago |
Septerna IncSEPN | 4 | Strong Buy | $25.00 | N/A | Reiterates | a year ago |
Compass Pathways PLCCMPS | 2 | Hold | $6.00 | N/A | Downgrades | a year ago |
Aardvark Therapeutics IncAARD | 2 | Strong Buy | $50.00 | N/A | Reiterates | a year ago |
Krystal Biotech IncKRYS | 5 | Strong Buy | $215.00 | N/A | Reiterates | 2 years ago |
Spero Therapeutics IncSPRO | 4 | Hold | $5.00 | N/A | Downgrades | 2 years ago |
Tourmaline Bio IncTRML | 2 | Strong Buy | $25.00 | N/A | Reiterates | 2 years ago |
Zura Bio LtdZURA | 5 | Strong Buy | N/A | N/A | Reiterates | 2 years ago |
Longboard Pharmaceuticals IncLBPH | 16 | Hold | N/A | N/A | Downgrades | 2 years ago |
4d Molecular Therapeutics IncFDMT | 3 | Hold | N/A | N/A | Downgrades | 2 years ago |
Alector IncALEC | 2 | Strong Buy | N/A | N/A | Reiterates | 2 years ago |
Jasper Therapeutics IncJSPR | 1 | Strong Buy | N/A | N/A | Reiterates | 2 years ago |
Arrowhead Pharmaceuticals IncARWR | 1 | Strong Buy | N/A | N/A | Reiterates | 2 years ago |
Arcturus Therapeutics Holdings IncARCT | 1 | Strong Buy | N/A | N/A | Reiterates | 2 years ago |
Annexon IncANNX | 1 | Strong Buy | N/A | N/A | Reiterates | 2 years ago |
Arcellx IncACLX | 1 | Strong Buy | N/A | N/A | Reiterates | 2 years ago |
Rallybio CorpRLYB | 3 | Buy | $120.00 | N/A | Maintains | 2 years ago |
Xenon Pharmaceuticals IncXENE | 3 | Strong Buy | $65.00 | N/A | Reiterates | 2 years ago |
Ventyx Biosciences IncVTYX | 2 | Hold | $5.00 | N/A | Downgrades | 3 years ago |
Otis Worldwide CorpOTIS | 4 | Hold | $92.00 | N/A | Maintains | 3 years ago |
Chinook Therapeutics IncKDNY | 1 | Hold | $40.00 | N/A | Downgrades | 3 years ago |
Erasca IncERAS | 2 | Buy | $11.00 | N/A | Maintains | 3 years ago |
Bellus Health IncBLU | 3 | Hold | $14.75 | N/A | Downgrades | 3 years ago |
Atreca IncBCEL | 1 | Hold | $1.50 | N/A | Downgrades | 3 years ago |
Seagen IncSGEN | 1 | Hold | $229.00 | N/A | Downgrades | 3 years ago |
Neuphoria Therapeutics IncNEUP | 2 | Buy | $6.00 | N/A | Upgrades | 4 years ago |
Tg Therapeutics IncTGTX | 3 | Buy | $25.00 | N/A | Maintains | 4 years ago |
Myovant Sciences LtdMYOV | 3 | Hold | $27.00 | N/A | Downgrades | 4 years ago |
Regeneron Pharmaceuticals IncREGN | 3 | Hold | $760.00 | N/A | Downgrades | 4 years ago |
Zymeworks IncZYME | 1 | Buy | $15.00 | N/A | Initiates Coverage On | 4 years ago |
Icosavax IncICVX | 1 | Buy | $50.00 | N/A | Initiates Coverage On | 5 years ago |
Viracta Therapeutics IncVIRX | 1 | Buy | $45.00 | N/A | Initiates Coverage On | 5 years ago |
Biomarin Pharmaceutical IncBMRN | 2 | Buy | $100.00 | N/A | Upgrades | 6 years ago |
Cullinan Therapeutics IncCGEM | 1 | Buy | $55.00 | N/A | Initiates Coverage On | 6 years ago |
Beyondspring IncBYSI | 1 | Buy | $30.00 | N/A | Initiates Coverage On | 6 years ago |
Freeline Therapeutics Holdings PLCFRLN | 1 | Buy | $480.00 | N/A | Initiates Coverage On | 6 years ago |
Cymabay Therapeutics IncCBAY | 1 | Buy | $15.00 | N/A | Upgrades | 6 years ago |
Bluebird Bio IncBLUE | 6 | Buy | $2,000.00 | N/A | Upgrades | 7 years ago |
Regenxbio IncRGNX | 3 | Buy | N/A | N/A | Upgrades | 8 years ago |
Madrigal Pharmaceuticals IncMDGL | 3 | Buy | $250.00 | N/A | Upgrades | 8 years ago |
Shire PLCSHPG | 2 | Hold | N/A | N/A | Downgrades | 8 years ago |
Incyte CorpINCY | 3 | Strong Buy | $85.00 | N/A | Assumes | 8 years ago |
Ionis Pharmaceuticals IncIONS | 2 | Hold | N/A | N/A | Downgrades | 8 years ago |
Voyager Therapeutics IncVYGR | 2 | Hold | N/A | N/A | Downgrades | 8 years ago |
Bioverativ IncBIVV | 3 | Hold | N/A | N/A | Downgrades | 9 years ago |
Uniqure NvQURE | 1 | Buy | $22.00 | N/A | Initiates Coverage On | 9 years ago |
Adamas Pharmaceuticals IncADMS | 1 | Buy | $85.00 | N/A | Initiates Coverage On | 9 years ago |
Audentes Therapeutics IncBOLD1 | 2 | Hold | N/A | N/A | Downgrades | 9 years ago |
Theravance Biopharma IncTBPH | 1 | Buy | N/A | N/A | Initiates Coverage On | 9 years ago |
Spark Therapeutics IncONCE | 1 | Hold | $83.00 | N/A | Initiates Coverage On | 9 years ago |
Avexis IncAVXS | 1 | Buy | $120.00 | N/A | Initiates Coverage On | 9 years ago |
Abbvie IncABBV | 1 | Buy | $95.00 | N/A | Initiates Coverage On | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.